<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-ijms-22-01285">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wetzel</surname>
    <given-names>C.H.</given-names>
   </name>
   <name>
    <surname>Hermann</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Behl</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Pestel</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Rammes</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Zieglgansberger</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Holsboer</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Rupprecht</surname>
    <given-names>R.</given-names>
   </name>
  </person-group>
  <article-title>Functional antagonism of gonadal steroids at the 5-hydroxytryptamine type 3 receptor</article-title>
  <source>Mol. Endocrinol.</source>
  <year>1998</year>
  <volume>12</volume>
  <fpage>1441</fpage>
  <lpage>1451</lpage>
  <pub-id pub-id-type="doi">10.1210/mend.12.9.0163</pub-id>
  <pub-id pub-id-type="pmid">9731711</pub-id>
 </element-citation>
</ref>
